Stratificare listed in top 5 Startups


Innovation Analysts from StartUs Insights recently looked into emerging technologies and analyzed 82 pharma startups tackling neglected tropical diseases and in their analysis, StratifiCare emerged as on of the top 5 startups to watch out for.

For this research, StartUs Insights identified 82 relevant solutions and picked 5 to showcase  below. The companies were chosen based on a data-driven startup  scouting approach, taking into account factors such as location,  founding year, and technology among others. Depending on your specific  criteria, the top picks might look entirely different.

The Global Startup Heat Map above highlights 5 startups & emerging companies  developing innovative pharma solutions for neglected tropical diseases. Moreover, the Heat Map reveals regions that observe a high startup  activity and illustrates the geographic distribution of all 82 companies we analyzed for this specific topic.

StratifiCare – Predicting Severe Dengue

Dengue fever is one of the most common NTDs affecting millions of people every year. Even  though the majority of the dengue infections are mild, severe forms of dengue often result in death. Accurate and early prediction of dengue disease progression significantly reduces the fatality risk associated with severe dengue.

StratifiCare provides a severe dengue prediction kit. It uses a set of proprietary biomarkers and a common laboratory assay platform. The solution is currently in the clinical development stage. The kit is able to deliver accuracy with 90% sensitivity and 97% specificity, in turn, reducing hospitalization costs.

Original article here:


All Posts

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!